Organisation profile
Organisation profile
SIREN
The SARS-CoV-2 Immunity and Reinfection EvaluatioN (SIREN) study is a prospective cohort study of hospital-based healthcare workers across the UK. It was established in 2020 as a pandemic response study, with over 44,000 healthcare workers recruited from 135 NHS trusts/health boards. The study initially investigated SARS-CoV-2 reinfections and the durability of immunity following infection, and subsequently COVID-19 vaccination. It has expanded its scope to evaluate Winter Pressures on the healthcare workforce, and questions of immunity more broadly. SIREN study - GOV.UK (www.gov.uk)
Key Workstreams
- Monitoring SARS-CoV-2 and respiratory infections and assessing risk factors for infection in UK healthcare workers
- Evaluating protection following infection and vaccination
- Pandemic preparedness
- Understanding immunity around SARS-CoV-2 and other respiratory viruses
- Quantifying the impact of Winter Pressures on the NHS workforce
- Exploring the burden of AMR and the microbiome in healthcare workers
- Mixed-methods research and evaluation
- Participant involvement in research
Collaborations
- World Health Organisation (Europe Region)
- The Francis Crick Institute
- The Wellcome Sanger Institute
- University College London
- University of Cardiff
- University of Cambridge
- University of Oxford
- University of Liverpool
- University of Sheffield
- Newcastle University
- University of Birmingham
- Birmingham City University
- Imperial College London
- University of Glasgow
- University of Edinburgh
- Pirbright Institute
- British Society of Immunology
- Seromyx
Data and Samples Accessibility Statement
All data is stored in a centralised database, including questionnaires, testing and all data from collaborations. We are committed to making the anonymised SIREN dataset available to researchers, within appropriate ethical and information governance guidelines.
We aim to develop the SIREN biobank into an accessible resource for the public health and medical research community, ensuring adherence to ethical and data protection safeguards.
For more information, please contact the SIREN team at: [email protected]
Fingerprint
Collaborations and top research areas from the last five years
-
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022
the SIREN Study Group, Jan 2024, In: Journal of Infection. 88, 1, p. 30-40 11 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Scopus) -
Prevalence and impact of persistent symptoms following SARS-CoV-2 infection among healthcare workers: A cross-sectional survey in the SIREN cohort
SIREN Study Group, Oct 2024, In: Journal of Infection. 89, 4, 106259.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study
the SIREN Study Group & Crick COVID Immunity Pipeline, Nov 2023, In: Journal of Infection. 87, 5, p. 420-427 8 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Citations (Scopus)